Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 1548
  • Home
  • Print this page
  • Email this page


 
   Table of Contents      
LETTER TO THE EDITOR
Year : 2019  |  Volume : 67  |  Issue : 2  |  Page : 312

Response to comment on: Validating the pachychoroid disease spectrum using multimodal imaging


Department of Vitreoretina, M. M. Joshi Eye Hospital, Hosur, Hubli, Karnataka, India

Date of Web Publication23-Jan-2019

Correspondence Address:
Dr. Apoorva Ayachit
M. M. Joshi Eye Hospital, Gokul Road, Hosur, Hubli - 580 021, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijo.IJO_1870_18

Rights and Permissions

How to cite this article:
Ayachit G, Ayachit A, Nadgir H, Joshi S. Response to comment on: Validating the pachychoroid disease spectrum using multimodal imaging. Indian J Ophthalmol 2019;67:312

How to cite this URL:
Ayachit G, Ayachit A, Nadgir H, Joshi S. Response to comment on: Validating the pachychoroid disease spectrum using multimodal imaging. Indian J Ophthalmol [serial online] 2019 [cited 2019 Apr 25];67:312. Available from: http://www.ijo.in/text.asp?2019/67/2/312/250669



Dear Sir,

We thank Sheth et al. for their interest in our case. They present a very well-illustrated follow-up of a case of pachychoroid over 4 years.[1]

In their case, there is a progression of pachychoroid pigment epitheliopathy (PPE) to central serous chorioretinopathy (CSC), pachychoroid neovasculopathy (PCN), and finally polypoidal choroidal vasculopathy (PCV). This progression is well known in the pathogenesis of pachychoroid disease spectrum. The novelty of our case, however, was simultaneous presentation of both CSC and PCV along with emphasis on optical coherence tomography angiography features. Polyps and choroidal neovascularization in the setting of chronic CSC are well known.[2] This aspect is getting increased attention since the introduction of the concept of pachychoroid. We wish to reiterate that the key focus of our case was the possibility of simultaneously having both CSC and PCV as also illustrated in a series by Manayath et al.[3]

We feel that Dr. Sheth's case would have been an interesting adjunct to our case had they shown an example where there were PPE, CSC, neovasculopathy, and PCV at the same point in time. We agree that our patient did not have PCN in addition to having PPE, CSC, and PCV. Their case merely shows progression of pachychoroid and not simultaneous presentation like in our case. It seems like an addition only because of the demonstration of imaging features of PCN, in a longitudinal follow-up.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Sheth JU, Giridhar A. Comment on: Validating the pachychoroid disease spectrum using multimodal imaging. Indian J Ophthalmol 2019;67:310-1.  Back to cited text no. 1
  [Full text]  
2.
Park H, Kim I. Clinical characteristics of polypoidal choroidal vasculopathy associated with chronic central serous chorioretionopathy. Korean J Ophthalmol 2012;26:15.  Back to cited text no. 2
    
3.
Manayath G, Shah V, Saravanan V, Narendran V. Polypoidal choroidal vasculopathy associated with central serous chorioretinopathy: Pachychoroid spectrum of diseases. Retina 2018;38:1195-204.  Back to cited text no. 3
    




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
References

 Article Access Statistics
    Viewed266    
    Printed1    
    Emailed0    
    PDF Downloaded46    
    Comments [Add]    

Recommend this journal